Physician

Joel Matthew Michalski, MD, PHD

According to 2025 Medicare claims, Joel Michalski, MD, PHD (NPI: 1437599248) practices hematology/oncology in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY WEST, PC (NPI: 1932178530; TIN: 470754790) and primary practice location at 68130-2042. Michalski is affiliated with the Think ACO, LLC (ACO ID: A2773), NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), Caravan Health ACO 50 LLC (ACO ID: A5160), and Main Street Rural Health Maple ACO LLC (ACO ID: A5401), participating under the MSSP model.

Michalski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 709 traditional Medicare patients, billed 176,175 HCPCS/CPT codes, and received $3,009,053 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,727 prescription claims across 187 beneficiaries totaling $4,685,420 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 13 claims. Open Payments data shows 77 records totaling $517,059. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $385,436 to $3,009,053. Similarly, Part D prescription costs have moved sharply higher in recent years, from $26,288 to $4,685,420. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	275	27,449	$385,436
2020	586	88,738	$2,000,825
2021	673	142,346	$1,653,672
2022	897	150,066	$2,374,436
2023	869	202,763	$3,647,024
2024	709	176,175	$3,009,053

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	56	372	$26,288
2016	34	416	$19,314
2017	33	116	$12,335
2018	N/R	18	$3,138
2019	26	76	$78,806
2020	71	430	$473,246
2021	111	990	$1,175,531
2022	132	1,079	$1,014,471
2023	159	1,323	$2,115,713
2024	187	1,727	$4,685,420

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$716
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	41	$2,186
2022	N/R	125	$3,988
2023	N/R	11	$163
2024	N/R	13	$175

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	99	180	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	398	1,041	$87
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	168	256	$12
80053	Blood test, comprehensive group of blood chemicals	175	755	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	209	964	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	48	1,388	$638,252
Lenalidomide	Lenalidomide	33	896	$514,341
Ayvakit	Avapritinib	12	360	$467,625
Revlimid	Lenalidomide	20	539	$383,876
Lenvima	Lenvatinib Mesylate	16	480	$381,550

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A5120	Skin barrier, wipes or swabs, each	N	N/R	13	$175

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$3,391	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	47	$513,668	Exelixis Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joel Matthew Michalski, MD, PHD?

Tedicare shows public-source Medicare data for Joel Matthew Michalski, MD, PHD (NPI 1437599248), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joel Matthew Michalski, MD, PHD have ACO affiliation data?

Joel Matthew Michalski, MD, PHD is shown with ACO affiliation data for Think ACO, LLC (MSSP, ACO ID A2773), NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Main Street Rural Health Maple ACO LLC (MSSP, ACO ID A5401).

What billing organization is linked to Joel Matthew Michalski, MD, PHD?

Joel Matthew Michalski, MD, PHD is linked to ONCOLOGY HEMATOLOGY WEST, PC (billing NPI 1932178530) in the available physician profile data.

Does Joel Matthew Michalski, MD, PHD have Open Payments data?

Joel Matthew Michalski, MD, PHD has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.